Boehringer Ingelheim Animal Health – Pexion

Boehringer Ingelheim Animal Health beauftragt ANIMA RES mit der Visualisierung der Wirkweise von Pexion.
Pexion wird zur zielgerichteten Behandlung von Epilepsie bei Hunden eingesetzt. Entgegen der herkömmlich eingesetzten Sedativa, zielt der in Pexion enthaltene Wirkstoff Imepitoin auf die für den Neurotransmitter GABA spezifischen Rezeptoren im Gehirn ab. Die Aktivierung von GABA sorgt für Verringerung der elektrischen Aktivität im Gehirn und bewirkt dadurch eine Reduktion der Anfallsfrequenz.

 

Testimonial:
“I was part of a team who had the opportunity to work with ANIMA RES. Our project for the mode of action video for our product was a great experience thanks to the teamwork of ANIMA RES. With the challenge in communicating complicated neurological concepts, the combination of technical savvy (scientific and animation technology) and creativity of the ANIMA RES team made working together a pleasure. The team was available to us when needed, accommodating to our sometimes fast-changing requests, and provided suggestions to make our video better on each revision. This was achieved not only with professionalism but also with a friendly understanding. The creative exchange from initial concept to voice narration produced a video that we are proud to show to our customers. I look forward to working with ANIMA RES again on another piece!”

Dr. Sandra Siegel, Global Technical Manager – Boehringer Ingelheim Animal Health GmbH